Find out more about who we are, what we do and the people behind Epitopea.
Find out what makes us unique and the work we do with our revolutionary new platform.
All the latest company news, press releases and updates from Epitopea.
Contact

News & Events

Revealing the true targets for next generation immunotherapies.
Learn More

Epitopea wins the 3rd annual Sweet BioPharma Day competition

Date: April 14, 2023 |
Epitopea wins the 3rd annual Sweet BioPharma Day competition LAVAL, Québec--(BUSINESS WIRE)--BIOQuébec, CQDM, Fonds de solidarité FTQ and adMare BioInnovations, […]
Read More

Epitopea Featured in BioWorld

Date: May 11, 2022 |
Epitopea closes $14M seed round for tumor antigen discovery Epitopea Ltd. raised $13.6 million in seed financing to take forward […]
Read More

Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics

Date: April 25, 2022 |
Novel CryptigenTM technology unlocks full potential of Tumour Specific Antigens CAMBRIDGE, UK and MONTREAL, CANADA, 25 April 2022 - Epitopea, […]
Read More

BioTrinity 2022: 26th & 27th April 2022

Date: April 4, 2022 |
Epitopea will be attending BioTrinity 2022 from the 26th to 27th April 2022. BioTrinity is an established, must-attend London conference, […]
Read More
Revealing the true targets for next generation immunotherapies
© 2022 – 2024 Epitopea Ltd | All Rights Reserved
Created by FDM Digital